O
31
-8
NVDA
68
-3
PEG
53
-5
MCK
75
-3
LUV
58
-5
WMT
60
-6
GM
74
-8
DE
50
-18
ADM
34
-10
IFF
48
-2
WEC
65
-5
MDLZ
40
2
WFC
72
-8
CNP
50
-2
KEY
60
-7
HCA
70
-5
GILD
60
-3
KSS
39
-7
CSX
31
-8
CI
40
-8
O
31
-8
NVDA
68
-3
PEG
53
-5
MCK
75
-3
LUV
58
-5
WMT
60
-6
GM
74
-8
DE
50
-18
ADM
34
-10
IFF
48
-2
WEC
65
-5
MDLZ
40
2
WFC
72
-8
CNP
50
-2
KEY
60
-7
HCA
70
-5
GILD
60
-3
KSS
39
-7
CSX
31
-8
CI
40
-8
Financhill
Back

CRISPR Therapeutics AG Stock Predictions

Your Portfolio's Boring. This Company Isn't And It's Early

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio
Sell
28

CRSP
CRISPR Therapeutics AG

Last Price:
$37.28
Seasonality Move:
7.25%

7 Day Trial

ALL ACCESS PASS

$ 7

Is the Traditional House Obsolete?

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.

CRISPR Therapeutics AG Stock Forecast

  • Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 41.8% based on the past 8 years of stock performance.
  • CRISPR Therapeutics AG has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is CRISPR Therapeutics AG Stock Undervalued?
    The current CRISPR Therapeutics AG [CRSP] share price is $36.99. The Score for CRSP is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will CRISPR Therapeutics AG Stock Go Up Next Year?

  • Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 41.8% based on the past 8 years of stock performance.

CRISPR Therapeutics AG Stock Rating

Sell
28
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG overpriced?

  • CRISPR Therapeutics AG has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

CRISPR Therapeutics AG Stock Price History

Is CRSP stock going to rise?

  • The current trend is moderately bullish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
crisprtx.com

52-Week Data

52-Week High:
67.88
52-Week Low:
30.04

Prediction Charts

Market Cap:
3.2B
Price in USD:
36.99
Volume:
2M
Beta:
2.03

Technical Analysis

SMA50:
37.71
SMA100:
40.12
SMA200:
44.05
52-Wk Change:
-32.45%

Stock Predictions

  • Is CRISPR Therapeutics AG stock public?
    Yes, CRISPR Therapeutics AG is a publicly traded company.
  • What is the CRISPR Therapeutics AG stock quote today?
    The CRISPR Therapeutics AG stock price is 36.99 USD today.
  • How to buy CRISPR Therapeutics AG stock online?
    You can buy CRISPR Therapeutics AG shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-2 38.18 38.25 39.38 38.00
May-5 37.88 37.62 38.49 37.33
May-6 36.92 33.16 36.97 33.03
May-7 34.51 34.25 34.64 33.50
May-8 34.88 36.14 36.86 34.12
May-9 36.39 35.62 37.34 35.55
May-12 36.54 37.59 38.02 36.26
May-13 37.74 37.22 37.90 36.29
May-14 37.21 35.60 38.64 35.38
May-15 35.32 36.31 36.36 34.87
May-16 37.30 38.77 38.98 36.71
May-19 38.19 38.68 39.00 37.70
May-20 38.81 39.25 40.27 37.74
May-21 38.80 36.99 39.41 36.88

CRISPR Therapeutics AG Earnings

CRISPR Therapeutics AG Earnings Report: Per Share CRISPR Therapeutics AG Earnings Q1 Q2 Q3 and Q4 last year and next year.

CRISPR Therapeutics AG Forecast Revenue Growth

CRISPR Therapeutics AG Stock Analysis: Historical quarterly revenues per share for CRISPR Therapeutics AG and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, an increase next quarter of $0.14 per share, a decrease this year of $0.31 per share, and an increase next year of $1.03 per share.

* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.